Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-22 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. |
| 2016-04-21 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. |
| 2017-04-26 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. |
| 2018-04-30 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. |
| 2019-05-07 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. |
| 2020-05-29 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University... extensive experience in the research and development of novel compounds. |
| 2021-04-26 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. |
| 2022-05-12 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. Because of Dr. Gilman’s extensive experience in the research and development of novel compounds, including anti-infectives that address highly drug resistant and invasive pathogens, we believe he is able to make valuable contributions to our Board. |
| 2022-08-19 | Steven C. Gilman, Ph.D. |
| 2023-05-01 | Dr. Gilman served as the Chairman of the board of directors and President and Chief Executive Officer of ContraFect Corporation, a biotechnology company. He has held scientific, business and academic appointments. |
| 2024-04-25 | Dr. Gilman received his Ph.D. and MS degrees in microbiology from Pennsylvania State University, his post-doctoral training at Scripps Clinical and Research Foundation and received a B.A. in microbiology from Miami University of Ohio. Because of Dr. Gilman’s extensive experience in the research and development of novel compounds, including anti-infectives that address highly drug resistant and invasive pathogens, we believe he is able to make valuable contributions to our Board. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-20 | Steven C. Gilman, Ph.D., a director since January 2015... Mr. Rubino (Chair), Ms. Hagen and Dr. Gilman were members of the Compensation Committee during the fiscal year ended December 31, 2019... DIRECTOR COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2019: Steven Gilman: $220,085. |
| 2021-03-19 | Steven C. Gilman, Ph.D., a director since January 2015, served as the Chairman of the board of directors and Chief Executive Officer of ContraFect Corporation until his retirement in April 2019. ... Dr. Gilman received his B.A. in microbiology from Miami University of Ohio and a Ph.D. and M.S. degree in microbiology from Pennsylvania State University. ... Vericel Board committee(s): Compensation Committee ... Director compensation table: Steven C. Gilman Fees Earned or Paid in Cash($) 47,000, Stock Awards($) 25,480, Option Awards($) 117,439, Total($) 189,919. |
| 2022-03-17 | Steven C. Gilman, Ph.D., a director since January 2015. ... Vericel Board committee(s): Compensation Committee ... Director compensation table: Steven C. Gilman total $477,970. |
Data sourced from SEC filings. Last updated: 2026-02-03